img_outline squiggle_edited_edited.png

Relevate Health Acquires Axon Communications

Combined proprietary capabilities expand healthcare marketing insight, access, and engagement

February 22, 2022

Cincinnati, OHRelevate Health continues its aggressive growth strategy, announcing the acquisition of Boston-based Axon Communications and its proprietary suite of digital healthcare professional (HCP), field team, and patient engagement marketing products. Integrating Axon’s products and capabilities expands Relevate Health’s product line and enhances its capabilities to generate brand growth nationally through local relevance, delivering benchmark beating ROI to pharmaceutical, biotechnology, and medical device clients. Denver-based Mountaingate Capital, known for their “customer-centric buy-and-build” approach, backed the Axon deal.


“Axon was the clear choice when selecting an organization and elevates our HCP engagement capabilities in the market,” states Jeff Spanbauer, Relevate Health CEO. “By adding Axon, we now offer clients the market’s most comprehensive, data-driven marketing capabilities that create local relevance with national scale through unique insights, enhanced HCP access, and the capability to continuously engage HCPs in a relevant manner.”


With innovative products such as MyDoc Personalized Patient Education, KOLCast, and REPCast, Axon is the leading innovator in live and remote video capture, custom digital solutions, and multichannel distribution for peer-to-peer and patient education, and boasts a highly scalable, nationwide digital film crew. Axon’s proprietary products enhance field team access, catalyzing HCP engagement and activation. Combined with Relevate Health’s unmatched data-insights and locally targeted KOL-led and rep-activated marketing products, the firm now offers an integrated suite of insight and engagement solutions for brands targeting HCPs and patients. “Axon adds products that open doors and increases physician access to drive behavioral change in partnership with our clients’ local field force,” said Spanbauer.


“With increasing demand for our products, we needed partners that have the scale and experience to support our rapid growth. Mountaingate Capital and Relevate Health are the perfect fit. Their proven track record of enterprise growth, as well as analytics and omnichannel capabilities, helps us more effectively engage HCPs and patients for our clients,” says Relevate’s newest board member, Chris Mutkoski. “Bringing our complementary product lines together is a huge win for brands, HCPs, and patients,” adds Laney Mutkoski. Axon Communications was co-founded in 2006 by husband-and-wife team, Chris and Laney Mutkoski.


Relevate Health’s headquarters remains in Cincinnati, with additional offices in New Jersey and Boston, employing over 160.


Founded in 2007, Relevate Health is an award-winning healthcare marketing agency for pharmaceutical, biotech and medical device brands, recognized by MM&M, PM360, MedAdNews and more. Learn more at www.RelevateHealth.com.


For more information on Axon Communications and their unique products and solutions, please visit www.AxonRx.com.


Mountaingate Capital is a Denver-based private equity firm that specializes in building and empowering companies with strong growth potential and engaged leadership teams. Mountaingate has been honored for three consecutive years as one of the most founder-friendly private equity firms by Inc. Mountaingate’s focus on organic growth coupled with its proven customer-centric buy-and-build approach and shared equity ownership with management creates more value for the end customer, while forging stronger, more collaborative, and more successful partnerships with management teams. Mountaingate targets investments in new platform companies with $5 million to $25 million of EBITDA, as well as add-on acquisitions of any size. For more information on Mountaingate, please visit www.Mountaingate.com.